Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Anthony Shuber, Greg Lucier, Craig Tuttle


Nabsys said that Anthony Shuber has joined the company as vice president and chief scientific officer. He comes to Nabsys from Ignyta, an oncology precision medicine firm, where he served as chief technology officer. Prior to joining Ignyta, Shuber was co-founder and CTO of Predictive Biosciences, and scientific co-founder of Exact Sciences. He also previously worked for Genzyme Genetics/Integrated Genetics and Genetics Institute.

Former Life Technologies CEO and chairman Greg Lucier has joined the board of directors at Invuity, a medical device company based in San Francisco. Prior to Life Tech, Lucier held senior management positions at General Electric, most recently CEO and president of Medical Systems Information Technologies for GE Healthcare. He holds an MBA from Harvard Business School and a BS in industrial engineering from Pennsylvania State University.

Former Transgenomic President and CEO Craig Tuttle was named president of private investment firm Prairie Ventures. Tuttle was also the president of Duke Scientific, which he sold to Fisher Scientific, now part of Thermo Fisher Scientific, and was president of Applied Biotech and Seradyn within the Apogent group, now also Thermo Fisher.